BIOMOLMACS
Innovative Training Networks (ITN)
Call: H2020-MSCA-ITN-2019
The main aim of the project BIOMOLMACS is to establish a multidisciplinary training network on the emerging topic of molecular machines. In the last decades, great efforts have been spent on the development of synthetic strategies for the creation of molecular machines, and these efforts have been acknowledged by the Nobel committee in 2016. The next important step is to incorporate the molecular machines in devices with application potential. For this purpose, the machines will be integrated in mesoscopic assemblies by employing well-defined polymeric components with structural and functional control. Sequence controlled polymers open up greater possibilities in the precise formation of nanoparticles such as polymersomes, and even support the generation of artificial cells. The combined molecular toolbox of molecular machines and precisely designed synthetic macromolecules will support the design of devices with innovative nanomedical application potential. 15 Early Stage Researchers will be trained on the design, synthesis, and characterization of such complex (macro)molecular building blocks, their subsequent devices, as well as their utilization in artificial and living cells. Besides, biophysical understanding of molecular interactions in living/synthetic systems will bridge the gap between fundamental and applied research.
We are currently searching for a motivated Phd student linked to this project – for more, download the Job Offer here!
List of Participating Organizations
(1) The University of Warwick – United Kingdom – Department of Chemistry – Dr. Remzi BECER
(2) University of Groningen – Netherlands – Stratingh Institute for Chemistry – Prof. Ben FERINGA
(3) Eindhoven University of Technology – Netherlands – Department of Chemical Engineering & Chemistry – Prof. Jan van HEST
(4) Centro de Investigación Príncipe Felipe – Spain – Polymer Therapeutics Lab – Prof. María J. VICENT
(5) Université de Bordeaux – France – Laboratoire de Chimie des Polymères Organiques – Prof. Sébastien LECOMMANDOUX
(6) University of Manchester – United Kingdom – School of Chemistry – Prof. David LEIGH
(7) Max-Planck-Institute of Biochemistry – Germany – Dept. Cellular and Molecular Biophysics – Prof. Petra SCHWILLE
(8) Imperial College London – United Kingdom – Department of Medicine – Prof. Robin SHATTOCK
(9) University of Basel – Switzerland – Department of Chemistry – Prof. Wolfgang MEIER
(10) Avroxa BVBA – Belgium – R&D – Prof. Richard Hoogenboom
(11) Polypeptide Therapeutic Solutions S.L. – Spain – R&D – Dr. Vicent J. NEBOT
(12) SyMO Chem – Netherlands – R&D – Dr. Henk JANSSEN
Partner Organizations
Polymun Scientific Immunbiologische Forschung GmbH – Austria – Dr. Andreas Wagner
Data for non-academic beneficiaries
SyMO-Chem BV – Eindhoven – Netherlands www.symo-chem.nl
PTS – Valencia – Spain – www.pts-polypeptides.com
Avroxa BVBA – Ghent – Belgium – www.ultroxa.be